Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) …

MA Jordaan, O Ebenezer, N Damoyi, M Shapi - Heliyon, 2020 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed as the
causative virus of COVID-19 disease, which is currently a worldwide pandemic. Efavirenz, a …

Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations

M Hagar, HA Ahmed, G Aljohani… - International Journal of …, 2020 - mdpi.com
The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that
started in December 2019. The effective drug target among coronaviruses is the main …

Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV …

H Rai, A Barik, YP Singh, A Suresh, L Singh, G Singh… - Molecular Diversity, 2021 - Springer
The importance of the main protease (M pro) enzyme of SARS-CoV-2 in the digestion of viral
polyproteins introduces M pro as an attractive drug target for antiviral drug design. This study …

Amentoflavone derivatives significantly act towards the main protease (3CLPRO/MPRO) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular …

D Dey, R Hossain, P Biswas, P Paul, MA Islam… - Molecular …, 2023 - Springer
SARS-CoV-2 is the foremost culprit of the novel coronavirus disease 2019 (nCoV-19 and/or
simply COVID-19) and poses a threat to the continued life of humans on the planet and …

In silico identification of potent COVID-19 main protease inhibitors from FDA approved antiviral compounds and active phytochemicals through molecular docking: a …

V Chandel, S Raj, B Rathi, D Kumar - 2020 - preprints.org
The Novel Coronavirus (COVID-19) is a positive-sense single-stranded RNA ((+) ssRNA)
virus. The COVID-19 Main Proteases play very important role in the propagation of the Novel …

[HTML][HTML] Combined docking methods and molecular dynamics to identify effective antiviral 2, 5-diaminobenzophenonederivatives against SARS-CoV-2

M Ouassaf, S Belaidi, MM Al Mogren, S Chtita… - Journal of King Saud …, 2021 - Elsevier
The aim of this work is to contribute to the research in finding lead compounds for clinical
use, to identify new drugs that target the SARS-CoV-2 virus main protease (Mpro). In this …

[HTML][HTML] Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular …

P Indu, MR Rameshkumar, N Arunagirinathan… - Journal of Infection and …, 2020 - Elsevier
Background Outbreak of COVID-19 has been recognized as a global health concern since it
causes high rates of morbidity and mortality. No specific antiviral drugs are available for the …

In silico evaluation of prospective anti-COVID-19 drug candidates as potential SARS-CoV-2 main protease inhibitors

MAA Ibrahim, AHM Abdelrahman, KS Allemailem… - The Protein …, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emanating
human infectious coronavirus that causes COVID-19 disease. On 11th March 2020, it has …

Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study

S Banerjee, S Yadav, S Banerjee… - Journal of chemical …, 2021 - ACS Publications
COVID-19, an acute viral pneumonia, has emerged as a devastating pandemic. Drug
repurposing allows researchers to find different indications of FDA-approved or …

Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure …

S Kumar, PP Sharma, U Shankar… - Journal of Chemical …, 2020 - ACS Publications
The novel coronavirus, SARS-CoV-2, has caused a recent pandemic called COVID-19 and
a severe health threat around the world. In the current situation, the virus is rapidly …